Keyword
Quick search:
Content Search
Result Content Research
Result Content Research
1 Longeveron's Novel Therapy Looks to Tackle COVID-19, Flu-Related ARDS
2 COVID‐19 Acute Respiratory Distress Syndrome (ARDS): a Simulation Study of the Effects of Combination Therapy with Tocilizumab and Siltuximab
3 Lung transplantation for COVID-19-associated ARDS
4 UIC awarded $6 million to develop potential COVID-19 treatment | UIC Today
5 Acute Respiratory Distress Syndrome (ARDS) Pipeline Research Report 2021
6 Mesoblast Presents Respiratory Function Results of COVID-19 ARDS Trial at Pulmonary Disease Conference
7 Enlivex to Present at the ARDS Drug Development Summit 2021
8 Latest ATS/CSL Behring research grant recipient focuses on COVID-19 ARDS study
9 Ninety Day Survival Outcomes in COVID-19 ARDS Trial of Remestemcel-L Presented at ISCT Meeting on Advances in Cell & Gene Therapies for Lung Diseases
10 COVID-19 ARDS Focus of Latest American Thoracic SocietyCSL Behring Research Grant Recipient
11 Results of Biomarck Clinical and Preclinical Studies of BIO-11006 in ARDS to be Presented at the 2021 ARDS Drug Development Summit
12 Aridis' (ARDS) COVID Antibody Combo Neutralizes Delta Variant
13 Pluristem Brings ARDS Associated with COVID-19 Phase II Studies to Clinical Readout
14 Letter to the editor Effects of inhaled nitric oxide in COVID‐19‐induced ARDS – Is it worthwhile?
15 Is Aridis Pharmaceuticals Inc (ARDS) a Stock to Watch After Gaining 6.00% This Week?
16 Mesoblast Shares 90-Day Survival Outcomes After Remestemcel-L From COVID-19 ARDS Trial
17 Aridis Pharmaceuticals Announces Exclusive License of Suvratoxumab, a Phase 3-Ready Monoclonal Antibody, from AstraZeneca
18 Should You Add Aridis Pharmaceuticals Inc (ARDS) Stock to Your Portfolio Tuesday?
19 Pharma company announces potential new drug for COVID patients
20 Direct Biologics Announces FDA Acceptance of IND Application for a Phase I/II Clinical Trial Studying ExoFlo for Acute Respiratory Distress Syndrome | DNA RNA and Cells | News Channels
21 Lung transplantation for acute respiratory distress syndrome: A multicenter experience
22 High sedation needs of critically ill COVID-19 ARDS patients-A monocentric observational study
23 Carbon County Court – ARDS – Times News Online
24 Reversibility of total airway closure and alveolar consolidation in a COVID‐19 patient: A case study
25 Advancing precision medicine for acute respiratory distress syndrome
26 Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant
27 'You're not bulletproof': 50-year-old COVID survivor urges caution, vaccination after nearly dying from virus | University of Michigan
28 Global Acute Respiratory Distress Syndrome (ARDS) Market 2021 with Covid-19 Impact on Market Size, Share, Glob
29 Spontaneous pneumomediastinum and pneumothorax in COVID‐19 patients: A tertiary care experience
30 Where Does Wall Street Think Aridis Pharmaceuticals Inc (ARDS) Stock Will Go?
31 Comparison of characteristics and ventilatory course between coronavirus disease 2019 and middle east respiratory syndrome patients with acute respiratory distress syndrome
32 Aridis Pharmaceuticals Inc (ARDS) is lower by -0.39% in a Week, Should You Hold?
33 How past failure put Rhys McClenaghan on a course to an Olympic final
34 After-Hours Stock Movers 07/12: (PLXT) (ARDS) (EQ) Higher; (SLP) (TWO) (VOXX) Lower (more...)
35 COVID-19 vs Non-COVID-19 ARDS: Comparing Characteristics, Outcomes
36 Critical roles of cytokine storm and secondary bacterial infection in acute kidney injury development in COVID‐19: A multi‐center retrospective cohort study
37 Study identifies two distinct phenotypes of COVID-19-associated ARDS
38 MESOBLAST : PRESENTS RESPIRATORY FUNCTION RESULTS OF COVID-19 ARDS TRIAL AT PULMONARY DISEASE CONFERENCE (Form 6-K)
39 Diagnosis and management of acute respiratory distress syndrome
40 Donaghadee: Harbour time capsule recovery could cost £720k
41 Cancer May Be an Independent Risk Factor for ARDS in Critically Ill Patients
42 Ampio Prescription drugs to Current at Aspen Lung Convention | Colorado
43 Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study
44 Remestemcel-L reduces ARDS mortality in those under 65 years old
45 Deep Learning Algorithm Detects Acute Respiratory Distress Syndrome with Expert-Level Accuracy
46 Ards North Down council debate on Israel "student polictics at is worst"
47 RNA Cell Therapy for COVID-19 Related ARDS in Development
48 Pocket Warrior Glutone MD, your best immunity agent against infectious diseases
49 Pathogenic airway neutrophilia drives ARDS in Black patients with severe COVID-19 in case study
50 Science News Releases
51 ARDS COMMUNITY HOSPITAL AND HUGHES INSURANCE PARTNER ON PARK&RIDE SERVICE
52 DUP select new Ards and North Down councillor to replace seat vacated by MLA Stephen Dunne
53 Diagnosing ARDS Earlier and the Development of ICU Delirium in Patients With ARDS
54 Lung mechanics and hypoxemia in COVID-19 patients with ARDS
55 Fewer fungi types in lungs associated with more severe ARDS
56 Measuring Mortality in ARDS: Mechanical Power vs Ventilatory Variables
57 Effect of PEEP in COVID-19-Related ARDS Similar to Classical ARDS
58 Aridis Pharmaceuticals Inc (ARDS) drops 11.62% for July 23
59 Deep learning to detect acute respiratory distress syndrome on chest radiographs: a retrospective study with external validation
60 How Acute Respiratory Distress Syndrome (ARDS) May Be Affecting COVID-19 Patients
61 COVID-Related ARDS May Not Be So Different After All: An ICU Physician's View of What
62 Global Acute Respiratory Distress Syndrome (ARDS) Epidemiology Forecast to 2030
63 Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19
64 Desidustat prevents development of ARDS in Phase II COVID-19 trial…
65 COVID-19-Associated ARDS Can Be Treated With Extracorporeal Membrane Oxygenation
66 Researchers receive $5.1 million to expand clinical trial of drug to prevent ARDS in COVID-19 patients
67 Stem cell therapy for COVID-19 and ARDS
68 Effects of inhaled nitric oxide in COVID‐19–induced ARDS – Is it worthwhile?
69 Health Canada Provides Positive Feedback on Tetra Bio-Pharma's Application for ARDS-003 to be Studied in COVID-19 Patients at Risk of Developing Acute Respiratory Distress Syndrome
70 Management of ARDS due to COVID-19 infection
71 McCartney smashes 200m Breaststroke PB at Summer Meet
72 SARS‐CoV‐2–related ARDS in a maintenance hemodialysis patient: case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point‐of‐care ultrasound
73 Lung transplantation for the treatment of irreversible acute respiratory distress syndrome
74 FDA grants Fast Track designation to COVID-19 ARDS treatment
75 Aridis Pharmaceuticals Inc (ARDS) gains 0.88% for July 15
76 Aridis Pharmaceuticals Inc (ARDS) gains 2.27% for July 16
77 Enterprising duo plant ideas for wellbeing
78 Evaluation of PEEP and prone positioning in early COVID-19 ARDS
79 A new treatment that might keep COVID-19 patients off the ventilator
80 Goa: Day after Vishwajit Rane’s U-turn, Covid victims’ kin recall oxygen shortage
81 Acute Respiratory Distress Syndrome (ARDS) Epidemiology
82 Remestemcel-L Fast Tracked for ARDS Due to COVID-19
83 What is Acute Respiratory Distress Syndrome (ARDS)?
84 Severe COVID-19 With ARDS in a Sickle Cell Disease Patient
85 Effect of Prone Positioning on Intensity of Inspiratory Effort in ARDS
86 Acute respiratory failure mortality increases in United States and may worsen with COVID-19 pandemic
87 Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial
88 When coronavirus kills, the lung condition ARDS can be the culprit. Here's what you need to know.
89 Patients with ARDS, preexisting psychiatric illness more likely to develop ICU delirium
90 Marijuana Compound Could Help Acute Respiratory Distress Syndrome
91 Complement Inhibition and COVID-19: The Story so Far | ITT
92 COVID-19 and ARDS Educational Webinar: Recovery and Life After the ICU
93 Aqualung Therapeutics Plans A Phase 0 ARDS Trial for eNAMPT Monoclonal Antibody (Alt-100 Mab) Following Type B FDA Meeting
94 Studying a Surfactant Therapy for ARDS and COVID-19 Lung Injury
95 Coronavirus disease 2019 respiratory failure: what is the best supportive care for patients who require ICU admission?
96 Intentional cooling of the body may help improve acute respiratory distress syndrome
97 Study finds link between low fungi diversity and severity of ARDS
98 Immunosuppressive Drugs for Autoimmune Disease May Reduce Risk of ARDS in COVID-19 Hospitalizations
99 Opaganib shows promise in preventing ARDS-induced thrombosis
100 Some severe cases of coronavirus could result in brain damage, inability to walk